Primary Hypercortisolism.
Bravi CA.
Urol Clin North Am. 2025 May;52(2):193-204. doi: 10.1016/j.ucl.2025.01.002. Epub 2025 Feb 26.
Medical therapy in severe hypercortisolism.
Marques JVO, Boguszewski CL.
Best Pract Res Clin Endocrinol Metab. 2021 Mar;35(2):101487. doi: 10.1016/j.beem.2021.101487. Epub 2021 Jan 20.
Evaluation and Treatment of Patients With Hypercortisolism: A Review.
Miller BS, Auchus RJ.
JAMA Surg. 2020 Dec 1;155(12):1152-1159. doi: 10.1001/jamasurg.2020.3280.
Recent Advances on Subclinical Hypercortisolism.
Zavatta G, Di Dalmazi G.
Endocrinol Metab Clin North Am. 2018 Jun;47(2):375-383. doi: 10.1016/j.ecl.2018.01.003. Epub 2018 Apr 9.
Cushing's syndrome: Treatment and new therapeutic approaches.
Ferriere A, Tabarin A.
Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101381. doi: 10.1016/j.beem.2020.101381. Epub 2020 Jan 30.
Update on Hypercortisolism Therapy.
Arnaldi G, Trementino L.
Front Horm Res. 2016;46:87-105. doi: 10.1159/000443869. Epub 2016 May 17.
Comparison of methods to monitor dogs with hypercortisolism treated with trilostane.
Golinelli S, de Marco V, Leal RO, Barbarossa A, Aniballi C, Maietti E, Tardo AM, Galac S, Fracassi F.
J Vet Intern Med. 2021 Nov;35(6):2616-2627. doi: 10.1111/jvim.16269. Epub 2021 Oct 21.
Alcohol-induced Cushing syndrome. Hypercortisolism caused by alcohol abuse.
Besemer F, Pereira AM, Smit JW.
Neth J Med. 2011 Jul-Aug;69(7):318-23.
Clinical review: Diagnosis and treatment of subclinical hypercortisolism.
Chiodini I.
J Clin Endocrinol Metab. 2011 May;96(5):1223-36. doi: 10.1210/jc.2010-2722. Epub 2011 Mar 2.
Advances in the medical management of hypercortisolism: current strategies, monitoring, and emerging therapies.
Mosquera JE, Rahimi L, Hamidi O.
Curr Opin Endocrinol Diabetes Obes. 2025 Oct 1;32(5):222-232. doi: 10.1097/MED.0000000000000920. Epub 2025 Jul 17.
